Medicinski fakultet, Katedra za farmaciju
Organization name
Medicinski fakultet, Katedra za farmaciju
Parent OrgUnit
City
Novi Sad
Country
Serbia
OrgUnit's Researchers publications
(Dept/Workgroup Publication)
Type
Fulltext
Results 1-20 of 21 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
1 | 2018 | 12-oxo chenodeoxycholic acid potentiates doxorubicin-induced oxidative stress through Nrf2 axis in breast adenocarcinoma cells | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Jasmina Katanić ; Iva Barjaktarović ; Momir Mikov |
2 | 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Momir Mikov |
3 | 2018 | Bile acid potentiates apoptosis of human breast adenocarcinoma cells induced by doxorubicin | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Bogdanović G; Vesna Kojić ; Momir Mikov |
4 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
5 | 1-Jan-2017 | Bile acids as novel pharmacological agents: The interplay between gene polymorphisms, epigenetic factors and drug response | Nebojša Pavlović ; Bojan Stanimirov ; Momir Mikov |
6 | 1-Jan-2016 | Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria | Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Tijana Ostojić ; Svetlana Goločorbin-Kon ; Gordana Smieško ; Momir Mikov |
7 | 1-Jan-2019 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H. |
8 | 2016 | The effects of usodeoxycholic acid on cytotoxic activity and proapoptotic potential of doxorubicin in MCF-7 cell line | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Vesna Kojić ; Iva Barjaktarović ; Momir Mikov |
9 | 2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
10 | 1-Jan-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |
11 | 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov |
12 | 1-Jan-2016 | The influence of bile salts on the distribution of simvastatin in the octanol/buffer system | Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Saša Vukmirović ; Katarina Nikolić; Danica Agbaba; Momir Mikov |
13 | 1-Oct-2012 | An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden | Pavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir |
14 | 2-Sep-2016 | MICROVESICLE FORMULATION CONTAINING SODIUM 3 ,7 - DIHYDROXY-12- KETO-5 - CHOLANATE ENHANCES ORAL ABSORPTION OF CEFOTAXIME | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Mladena Lalić-Popović ; Boris Milijašević ; Bojan Stanimirov ; Saša Vukmirović ; Momir Mikov |
15 | 2019 | New pharmaceutical formulations and new indications for an old drug - methotrexate | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Maja Đanić ; Boris Milijašević ; Milica Paut Kusturica ; Ana Tomas Petrović ; Bojan Stanimirov ; Hani Al-Salami; Momir Mikov |
16 | 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat | Nebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov |
17 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
18 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
19 | 1-Dec-2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
20 | 2019 | Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Saša Vukmirović ; Jelena Lazić; Hani Al-Salami; Momir Mikov |